Evaluation of the Effects of Pharmaton Tablets on Mental Performance and Physical Fatigue in Nurses Working Night Shift
NCT02199847 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2014-07-25
Summary
The general aim of this study is to assess the effects of Pharmaton® Caplets on mental performance and physical fatigue in nurses and nursing auxiliaries working night shifts
Conditions
- Sleep Disorders, Circadian Rhythm
Interventions
- DRUG
-
Pharmaton® Caplets
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-06-30
- Primary Completion
- 2001-01-31
More Related Trials
-
Ramelteon for a Nap Prior to a Night Shift
NCT00595075 ·Status: COMPLETED ·Phase: NA
-
Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD
NCT00080288 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
NCT01091974 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
NCT00518986 ·Status: COMPLETED ·Phase: PHASE4
-
The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances
NCT02183714 ·Status: COMPLETED ·Phase: PHASE3
-
Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder
NCT00688142 ·Status: COMPLETED
-
Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance
NCT00711516 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability
NCT00368056 ·Status: COMPLETED ·Phase: PHASE3
-
Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)
NCT00078325 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Sleep and Psychological Functioning in People With Depression and Insomnia
NCT00247624 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
NCT05236842 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model
NCT03284931 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL
NCT00236080 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Delirium in Intensive Care by Melatonin
NCT03524937 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274
NCT02852395 ·Status: COMPLETED ·Phase: PHASE1
-
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
NCT01888497 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
NCT07082829 ·Status: RECRUITING ·Phase: PHASE1
-
Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome
NCT00079677 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)
NCT00798395 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy
NCT00078377 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss
NCT01096680 ·Status: COMPLETED ·Phase: PHASE2
-
Non-deceptive Application of Placebos in Insomnia
NCT03616652 ·Status: COMPLETED ·Phase: NA
-
Melatonin Treatment for Induced Transient Insomnia
NCT00950885 ·Status: COMPLETED ·Phase: NA
-
Management of Insomnia in Breast Cancer Patients
NCT01011218 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
NCT00228566 ·Status: COMPLETED ·Phase: PHASE3